These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31814827)

  • 1. Mapping the Germline and Somatic Mutation Interaction Landscape in Indolent and Aggressive Prostate Cancers.
    Mamidi TKK; Wu J; Hicks C
    J Oncol; 2019; 2019():4168784. PubMed ID: 31814827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of the Genomic-Epigenomic Interaction Landscape of Aggressive Prostate Cancer.
    Kumar Mamidi TK; Wu J; Hicks C
    Biomed Res Int; 2021; 2021():6641429. PubMed ID: 33511206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between Germline and Somatic Mutated Genes in Aggressive Prostate Cancer.
    Mamidi TKK; Wu J; Hicks C
    Prostate Cancer; 2019; 2019():4047680. PubMed ID: 31007957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating germline and somatic variation information using genomic data for the discovery of biomarkers in prostate cancer.
    Mamidi TKK; Wu J; Hicks C
    BMC Cancer; 2019 Mar; 19(1):229. PubMed ID: 30871495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer.
    Wu J; Mamidi TKK; Zhang L; Hicks C
    Int J Genomics; 2020; 2020():2641370. PubMed ID: 32724790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Germline and Somatic Mutation Information for the Discovery of Biomarkers in Triple-Negative Breast Cancer.
    Wu J; Mamidi TKK; Zhang L; Hicks C
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30909550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer.
    Wu J; Mamidi TKK; Zhang L; Hicks C
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31683572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the Genomic-Epigenomic Interaction Landscape in Triple Negative and Non-Triple Negative Breast Cancer.
    Wu J; Mamidi TKK; Zhang L; Hicks C
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic BRCA2 Mutations Shape the Somatic Mutational Landscape of Aggressive Prostate Tumors.
    Decker B; Karyadi DM; Davis BW; Karlins E; Tillmans LS; Stanford JL; Thibodeau SN; Ostrander EA
    Am J Hum Genet; 2016 May; 98(5):818-829. PubMed ID: 27087322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Landscape of DNA damage response gene alterations in breast cancer: A comprehensive investigation.
    Jin J; Cao J; Li B; Li T; Zhang J; Cao J; Zhao M; Wang L; Wang B; Tao Z; Hu X
    Cancer; 2023 Mar; 129(6):845-859. PubMed ID: 36655350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
    Na R; Zheng SL; Han M; Yu H; Jiang D; Shah S; Ewing CM; Zhang L; Novakovic K; Petkewicz J; Gulukota K; Helseth DL; Quinn M; Humphries E; Wiley KE; Isaacs SD; Wu Y; Liu X; Zhang N; Wang CH; Khandekar J; Hulick PJ; Shevrin DH; Cooney KA; Shen Z; Partin AW; Carter HB; Carducci MA; Eisenberger MA; Denmeade SR; McGuire M; Walsh PC; Helfand BT; Brendler CB; Ding Q; Xu J; Isaacs WB
    Eur Urol; 2017 May; 71(5):740-747. PubMed ID: 27989354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline mutations in PPFIBP2 are associated with lethal prostate cancer.
    Wu Y; Yu H; Zheng SL; Feng B; Kapron AL; Na R; Boyle JL; Shah S; Shi Z; Ewing CM; Wiley KE; Luo J; Walsh PC; Carter HB; Helfand BT; Cooney KA; Xu J; Isaacs WB
    Prostate; 2018 Dec; 78(16):1222-1228. PubMed ID: 30043417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?
    Cussenot O; Cancel-Tassin G; Rao SR; Woodcock DJ; Lamb AD; Mills IG; Hamdy FC
    BJU Int; 2023 Nov; 132(5):472-484. PubMed ID: 37410655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of
    Chen W; Xia W; Xue S; Huang H; Lin Q; Liu Y; Liu T; Zhang Y; Zhang P; Wang J; Yang Y; Dong B; Yu Z
    Front Oncol; 2022; 12():746102. PubMed ID: 35251954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
    Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
    Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
    Zhang J; Zhang S; Wang Y; Zhang XS
    BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutational profiles and germline polygenic risk scores in human cancer.
    Liu Y; Gusev A; Heng YJ; Alexandrov LB; Kraft P
    Genome Med; 2022 Feb; 14(1):14. PubMed ID: 35144655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
    Wu Y; Yu H; Zheng SL; Na R; Mamawala M; Landis T; Wiley K; Petkewicz J; Shah S; Shi Z; Novakovic K; McGuire M; Brendler CB; Ding Q; Helfand BT; Carter HB; Cooney KA; Isaacs WB; Xu J
    Prostate; 2018 Jun; 78(8):607-615. PubMed ID: 29520813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.
    Winter JM; Curry NL; Gildea DM; Williams KA; Lee M; Hu Y; Crawford NPS
    BMC Genomics; 2018 Jun; 19(1):450. PubMed ID: 29890952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction analysis between germline susceptibility loci and somatic alterations in lung cancer.
    Wang Y; Wang C; Zhang J; Zhu M; Zhang X; Li Z; Dai J; Ma H; Hu Z; Jin G; Shen H
    Int J Cancer; 2018 Aug; 143(4):878-885. PubMed ID: 29492964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.